JELD-WEN Holding, Inc. JELD 深 沪
等待开盘 06-24 09:30:00 美东时间
1.52
-0.140
-8.43%
华盛通- 最 高1.725
- 今 开1.63
- 成交量 310.03万股
- 最 低 1.51
- 昨 收 1.66
- 总市值 1.31亿
- 52周最高 6.975
- 市盈率 静 --
- 换手率 3.60%
- 52周最低 0.925
- 委 比 -86.67%
- 总股本 8615.13万
- 历史最高 42.27
- 量 比 2.07
- 振 幅 12.95%
- 历史最低 0.925
- 每 手 1
- 风险率 1.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Jeld-Wen expands environmental product declaration portfolio
Jeld-Wen Holding (JELD) has expanded its portfolio of Environmental Product Declarations, adding third-party verified disclosures for a range of building products sold in North America and Europe. The...
06-23 22:58
JELD-WEN Appoints Christian Michel as Executive Vice President and President, Europe
CHARLOTTE, N.C., June 8, 2026 /PRNewswire/ -- JELD-WEN Holding, Inc. (NYSE: JELD), a leading global manufacturer of building products, today announced the appointment of Christian Michel as ...
06-08 20:00
Herige unit Atlantem names Francois Bourgoin CEO
Herige unit Atlantem names Francois Bourgoin CEO Herige named François Bourgoin chief executive of Atlantem, effective June 16. Bourgoin brings 15 years of joinery industry experience, with prior senior roles at Hörmann, JELD-WEN, Knauf. Atlantem reported 2025 revenue of EUR 219.2 million. Disclaime
06-04 22:21
美股大行评级 | 潜在涨幅20%！15家机构集体上调AMD目标价；Lumentum、神经分泌生物科学、伊顿公司、美国电力等获多家大行上调目标价
今日重点评级关注：Citizens：维持Avalo Therapeutics"跑赢大市"评级，目标价从52美元升至62美元；BTIG：维持Avalo Therapeutics"买入"评级，目标价从40美元升至58美元
05-07 12:37
UBS Maintains Neutral on JELD-WEN Holding, Lowers Price Target to $1.6
UBS analyst John Lovallo maintains JELD-WEN Holding (NYSE:JELD) with a Neutral and lowers the price target from $3 to $1.6.
05-07 05:46
JELD-WEN Earnings Call: Progress Amid Mounting Pressure
JELD-WEN (($JELD)) has held its Q1 earnings call. Read on for the main highligh...
05-06 08:52
Transcript: JELD-WEN Holding Q1 2026 Earnings Conference Call
JELD-WEN Holding (NYSE:JELD) held its first-quarter earnings conference call on...
05-05 20:40
JELD-WEN Holding Raises FY2026 Sales Guidance from $2.950B-$3.100B to $3.050B-$3.200B vs $3.041B Est
JELD-WEN Holding (NYSE:JELD) raises FY2026 sales outlook from $2.950 billion-$3.100 billion to $3.050 billion-$3.200 billion vs $3.041 billion estimate.
05-05 04:38
JELD-WEN Holding Q1 Adj. EPS $(0.50) Misses $(0.29) Estimate, Sales $722.100M Beat $721.408M Estimate
JELD-WEN Holding (NYSE:JELD) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.29) by 72.41 percent. This is a 194.12 percent decrease over losses of $(0.17) per share from
05-05 04:38
Earnings Scheduled For May 4, 2026
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
